High-dose baclofen for the treatment of alcohol dependence (BACLAD study): A randomized, placebo-controlled trial
- 13 April 2015
- journal article
- research article
- Published by Elsevier BV in European Neuropsychopharmacology
- Vol. 25 (8), 1167-1177
- https://doi.org/10.1016/j.euroneuro.2015.04.002
Abstract
No abstract availableKeywords
Funding Information
- German Research Foundation (Cluster of Excellence EXC 257 NeuroCure)
This publication has 37 references indexed in Scilit:
- Extending the Treatment Options in Alcohol Dependence: A Randomized Controlled Study of As-Needed NalmefeneBiological Psychiatry, 2013
- High-Dose Baclofen for Treatment-Resistant Alcohol DependenceJournal of Clinical Psychopharmacology, 2012
- Suppression of Alcohol Dependence Using Baclofen: A 2-Year Observational Study of 100 PatientsFrontiers in Psychiatry, 2012
- Efficacy and Safety of Baclofen for Alcohol Dependence: A Randomized, Double‐Blind, Placebo‐Controlled TrialAlcohol: Clinical and Experimental Research, 2010
- Neurocircuitry of AddictionNeuropsychopharmacology, 2009
- Acute Interaction of Baclofen in Combination With Alcohol in Heavy Social DrinkersAlcohol: Clinical and Experimental Research, 2008
- Ethanol’s Molecular TargetsScience Signaling, 2008
- Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled studyThe Lancet, 2007
- Baclofen antagonizes nicotine‐, cocaine‐, and morphine‐induced dopamine release in the nucleus accumbens of ratSynapse, 2003
- The Obsessive Compulsive Drinking Scale: A Self‐Rated Instrument for the Quantification of Thoughts about Alcohol and Drinking BehaviorAlcohol: Clinical and Experimental Research, 1995